Sharechat Logo

Ryman Healthcare Limited - Annual Report 2022

Friday 17th June 2022

Text too small?

We are pleased to report a strong result delivered during this period  of considerable disruption. The resilience, commitment and professionalism of our Ryman team played a key role in helping us adapt quickly and respond decisively to the changing circumstances. Quite simply, their efforts have been magnificent. Our vertically-integrated business model proved particularly advantageous in maintaining the momentum of the business, allowing us to reallocate resources to the areas of most need. As a result, we have been able to keep our residents and team safe as well as build for the future, acquiring land, constructing new villages, selling completed and refurbished units and setting new benchmarks in clinical care.

These outcomes have served to enhance our reputation in the market  and cement our position as a market leader in the retirement sector. We remain committed to maintaining our leadership position, as well as generating increased returns to our shareholders and positioning Ryman for further growth in the years ahead. Providing care that in the words of our co-founder has got to be “good enough for Mum or Dad” is key to us achieving this. This ethos captures something truly unique in the spirit of Ryman and is what motivates our people every day. Our low resale stock, combined with mature care occupancy of  96 percent, demonstrates that our villages continue to be in  strong demand. In a year when we faced increased operating costs and could not trade or build for a significant amount of time, we are pleased with what the team has achieved.



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report
RAD - Radius Care Announces On-market Share Buyback Programme
MCY - New wind farm propels MCY renewables commitment to $1b